Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech

1.94
+0.05502.93%
Volume:174.97K
Turnover:337.03K
Market Cap:57.22M
PE:-0.88
High:1.95
Open:1.90
Low:1.89
Close:1.88
Loading ...

Fortress Biotech’s Subsidiary Merges with Sun Pharma

TIPRANKS
·
Yesterday

Fortress Biotech Inc. Reports Significant Turnaround with Net Loss Converted to $14.999M Profit; EPS Jumps to $0.57

Reuters
·
Yesterday

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

THOMSON REUTERS
·
30 May

Press Release: Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

Dow Jones
·
30 May

Checkpoint Therapeutics Inc. Announces April 2025 Agreement for Merger with Sun Pharmaceutical's Subsidiary

Reuters
·
30 May

Checkpoint Therapeutics Inc. Held Virtual Special Meeting on Merger Proposals

Reuters
·
29 May

Checkpoint Therapeutics Inc. Sets May 30, 2025, as Expected Closing Date for Merger with Sun Pharmaceutical Industries

Reuters
·
22 May

Avenue Therapeutics Inc. Reports Q1 Loss from Operations of $1.905M, Decrease from $3.708M in Prior Year

Reuters
·
21 May

Fortress Biotech Reports Q1 2025 Financial Highlights

TIPRANKS
·
20 May

Alliance Global Partners Sticks to Its Buy Rating for Fortress Biotech (FBIO)

TIPRANKS
·
20 May

Fortress Biotech Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
17 May

Fortress Biotech Inc - Sun Pharma to Buy Checkpoint Therapeutics, Transaction to Take Place on May 28, 2025

THOMSON REUTERS
·
16 May

Fortress Biotech Inc - FDA Accepts Nda for Cutx-101 With Pdufa Date Sept 30, 2025

THOMSON REUTERS
·
16 May

Fortress Biotech Q1 EPS $(0.48) Beats $(0.49) Estimate, Sales $13.14M Beat $11.62M Estimate

Benzinga
·
16 May

Press Release: Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Dow Jones
·
15 May

Checkpoint Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Press Release: Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates

Dow Jones
·
14 May

Checkpoint Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
09 May

Fortress Biotech Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
09 May

This Fortress Biotech Insider Increased Their Holding By 26% Last Year

Simply Wall St.
·
09 Apr